October 6, 2016
Pfizer to sell Hospira infusion therapy business to ICU Medical
Pfizer said on Thursday it would sell its global infusion therapy business, part of its $15 billion (11.8 billion pounds) Hospira acquisition last year, to ICU Medical Inc for $1 billion in cash and stock.